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Abstract We assessed the long-term renal complications in a
regional cohort of extremely low birth weight (ELBW)
children born in 2002–2004. The study group, comprising
78 children born as ELBW infants (88% of the available
cohort),was evaluatedwithmeasurementofserum cystatinC,
urinary albumin excretion, renal ultrasound, and 24-
h ambulatory blood pressure measurements. The control
group included 38 children born full-term selected from one
general practice in the district. Study patients were evaluated
at a mean age of 6.7 years, and had a median birthweight of
8 9 0g( 2 5 t h –75th percentile: 760–950 g) and a median
gestational age of 27 weeks (25th–75th percentile: 26–
29 weeks). Mean serum cystatin C levels were significantly
higher (0.64 vs. 0.59 mg/l; p=0.01) in the ELBW group.
Hypertension was diagnosed in 8/78 ELBW and 2/38 of the
control children (p=0.5). Microalbuminuria (>20 mg/g of
creatinine) was detected only in five ELBW children
(p=0.17). The mean renal volume was significantly lower
in the ELBW group (absolute kidney volume 81 ml vs.
113 ml; p<0.001, relative kidney volume 85 vs. 97%;
p<0.001). Abnormally small kidneys (<2/3 of predicted size)
were detected in 19 ELBW and four control children
(p=0.08). Multivariate logistic regression revealed that the
only independent risk factor for renal complications was
weight gained during neonatal hospitalization (odds ratio:
0.67; 95% confidence interval: 0.39–0.94). Serum cystatin C
and kidney volume are significantly lower in school-age
ELBW children. It is important to include systematic renal
evaluation in the follow-up programs of ELBW infants.
Keywords Preterm.ELBW.Microalbuminuria.Cystatin
C.Blood pressure.ABPM.Renal ultrasound.Kidney
volume
Abbreviations
ABPM Ambulatory blood pressure monitoring
ACR Urinary albumin to creatinine ratio
BP Blood pressure
DBP Diastolic blood pressure
ELBW Extremely low birth weight
GFR Glomerular filtration rate
MAP Mean arterial pressure
NICU Neonatal intensive care unit
SBP Systolic blood pressure
SGA Small for gestational age
VLBW Very low birth weight
Introduction
Advances in perinatal and neonatal care over the last
30 years have contributed to improved survival among
extremely low birth weight infants (ELBW), who are
defined as weighing less than 1,000 g at birth [1]. However,
acute complications during the perinatal period may be
followed by long-term physical or mental sequelae [2–4].
There are numerous studies assessing the future neurolog-
ical development of pre-term infants, but studies that focus
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is suggested between birth weight and renal size, number of
nephrons, systolic blood pressure, and albuminuria. Since
nephrogenesis continues until 36 weeks of gestation,
very preterm neonates (gestational age <32 weeks) are
likely to show a nephron deficit at birth. In Rodriguez et
al. [5], an autopsy study of premature infants (gestational
age <28 weeks) of extremely low birth weight (≤1,000 g)
showed markedly decreased radial glomerular counts
compared to mature infants. Glomerulogenesis continued
until 40 days of age but did not reach the level of mature
infants. Preterm birth is also associated with limited
postnatal kidney growth until the age of 24 months [6,
7]. Postnatal anatomical and physiological renal matura-
tion may be impaired by e.g., poor nutrition, clinical
complications such as nephrocalcinosis, or nephrotoxic
medications [8].
The aim of the present investigation was to determine
clinicalandfunctionalrenalparametersinschool-agechildren
weighing less than 1,000 g at birth and to assess the influence
of ELBW on kidney function. We compared selected
laboratory tests, ultrasound evaluation, and blood pressure
monitoringmeasurementsbetween6to7-year-oldELBWand
age-matched control full-term children. Our hypothesis was
that very preterm infants may have postnatal impaired
nephrogenesis that is detectable by abnormalities in renal
function in childhood. To our knowledge, this is one of the
few long-term observational studies examining the renal
outcome of such immature infants.
Materials
A cross-sectional observational study was conducted in the
Follow-up Pediatric Department of the Polish-American
Children’s Hospital between August 1, 2009 and October
31, 2010.
From 1 September, 2002, to 31 August, 2004, 169
newborns with birth weights ranging from 500 to 1,000 g
were born alive in the southeast district of Poland
(Małopolska region). All children were hospitalized in
three tertiary care Neonatal Intensive Care Unit (NICU)
referral centers in southeast Poland. Ninety-one infants
were discharged home from NICUs. All those who were
alive at the age of 6–7 years were invited to participate in
the follow-up study (n=89). Neonatal data used for the
study was recorded during their stay in an NICU daily in a
prospective manner and stored in computer databases. For
the purpose of the study, the following data was extracted
from the original databases: sex, birthweight, gestational
age, intrauterine growth, Apgar score, incidence of pre-
eclampsia, preterm rupture of membranes, chorioamnioni-
tis, the presence of respiratory distress syndrome (RDS), the
need for mechanical ventilation, surfactant administration, the
use of ibuprofen for patent ductus arteriosus (PDA), PDA
ligation, early and late-onset septic episodes, treatment with
aminoglycosides or vancomycin, the prevalence of intraven-
tricular hemorrhage (IVH), periventricular leukomalacia
(PVL), bronchopulmonary dysplasia (BPD)—defined as at
least 28 days of oxygen therapy and also defined as oxygen
therapy at 36 weeks post menstrual age (PMA), weight gain
during NICU stay, the length of hospitalization and the results
of neonatal renal ultrasound. Additionally, all charts were
manually reviewed to detect neonatal episodes of oliguria and
anuria.Thecontrolgroupincludedage-matchedchildrenfrom
one general practice (GP) office and the study was approved
by the Ethical Committee for Clinical Investigations of
Collegium Medicum, Jagiellonian University.
Methods
After signing of the informed consent by the parents, serum
cystatin C, microalbuminuria, renal ultrasound, and 24-
h ambulatory blood pressure measurements (ABPM) were
performed in all of the children. All parents were asked to
complete a questionnaire assessing the possibility of urinary
tract infections during infancy.
Serum cystatin C
Cystatin C was measured by a particle-enhanced immuno-
nephelometric assay (N Latex cystatin C, Dade Behring)
using a nephelometer (BN-II, Dade Behring, Marburg,
Germany). The normal value for children between 4 and
10 years of age was defined as 0.53–0.95 mg/l
Urinary albumin excretion
Twelve-hour pooled urine samples were used to assess
urinary albumin and creatinine. The concentration of
albumin was measured by a radioimmunological competi-
tion assay (ImmunoTech, Prague, Czech Republic). Urinary
creatinine was estimated by the dry chemistry method with
Vitros 5.1.FF machine (Ortho-Clinical Diagnostics,
Rochester, NY, USA). Total daily albumin excretion was
calculated as the ratio of urinary albumin (mg/l) to urinary
creatinine (mg/dl) (ACR). Microalbuminuria was defined as
an ACR >20 mg/g.
24-h ambulatory blood pressure measurements
ABPM was performed using a SPACELABS 90207 device
with a cuff the same size as the one used to measure casual
blood pressure and following the technique described by
the American Heart Association Council on High Blood
1096 Pediatr Nephrol (2011) 26:1095–1103Pressure Research [9]. The device was programmed to obtain
blood pressure (BP) readings every 20 min from 7:00 AM to
9:00 PM and every 30 min from 9:00 PM to 7:00 AM.
Recordings with at least 80% valid readings and at least one
reading every hour were considered for the analysis.
Sleep and wake periods were defined on the basis of a
diary completed by the child’s parents/guardians.
The following parameters were analyzed: mean
24-h systolic, diastolic, and mean arterial pressure (MAP),
mean day-time systolic, diastolic, and MAP, mean night-
time systolic, diastolic, and MAP. Original data was
converted to SD scores (z-scores).
Hypertension was diagnosed if at least one variable was
above the 95th percentile, according to reference values
published by Wühl et al. [10]
Moreover, BP load was calculated separately for the
awake and asleep periods. BP load was defined as the
percentage of valid ambulatory BP measures above a set
threshold value. The BP load was calculated with relation
to the threshold values indicated by the 95th percentiles for
SBP and DBP for sexes and the height percentile following
the values published in The Fourth Report on the
Diagnosis, Evaluation, and Treatment of High Blood
Pressure in Children and Adolescents [11]. Loads in excess
of 30% were considered elevated. Loads in excess of 50%
were considered severely elevated.
Nocturnal dipping was calculated using the following
formula: [mean daytime ABPM–mean nighttime ABPM]/
mean day ABPM × 100. Normal dipping was defined as
a ≥10% decline.
Renal ultrasound
Sonography was performed with a Philips Envisor HD, a
color Doppler machine, with a C2-5 MHz probe. For each
child examined, kidney length and width were calculated as
the average of three measurements. Renal measurements
were performed with children in the supine position,
scanning in the para-coronal view with the transducer
positioned to obtain the longest kidney dimension. Kidney
volume was calculated using the formula: (kidney length ×
kidney width × kidney thickness) × Pi/6.
Relative kidney length and volume measurements were
obtained by calculation of the ratio of actual to mean
reference renal measurements. The reference values of
kidney length and volume were calculated with the use of
formulas provided by Dinkel et al. [12]. Renal length was
adjusted for the patient’s height, and renal volume was
adjusted for the patient’s weight. The formulas used for the
predicted renal volume calculation were as follows:
(A) Left kidney volume=4.214 × body weight
0.823
(B) Right kidney volume=4.456 × body weight
0.795
The formula used for relative kidney volume calculation
was as follows:
(C) Relative kidney volume=(kidney volume measured
by ultrasound/predicted kidney volume) × 100%
Low renal volume was diagnosed if volume was below
two-thirds of the predicted value [13].
Outcome variables
The presence of renal complications was regarded as the
primary outcome variable. Renal complications were
diagnosed if at least two of the following abnormalities
were detected: (1) abnormal serum cystatin C level, (2)
microalbuminuria, (3) hypertension, (4) and low renal
volume. Secondary outcome variables included: serum
cystatin C level, urinary albumin/creatinine ratio, 24-
h day-time and night-time systolic BP (SBP), diastolic
(DBP) and mean arterial pressure (MAP), absolute and
relative kidney volume.
Statistical analysis
Limited data exist regarding renal complication frequencies
in preterm populations. Sample size estimations were based
on the following assumptions: (a) the follow-up rate would
be as high as 90% (80 ELBW children), and (b) the
frequency of renal problems in an unselected group of 40
healthy children was 5%. Estimation specified an 80%
chance of detecting 8% difference (with probability of type
I error (two-sided) alpha=0.05). The sample size calcula-
tion was performed using PS Power and Sample Size
Calculations software (Version 2.1.30, February 2003,
http://www.mc.vanderbilt.edu/prevmed/ps/index.htm)[ 14].
The comparison between the groups utilized Student’s t
test, the Mann–Whitney U test, Chi-square test or Fisher’s
exact test, as appropriate. Next, different factors associated
with renal problems in univariate analyses were entered as
covariates for the logistic regression analysis. Logistic
regression was used to estimate odds ratios for renal
problems among former ELBW infants.
Data was analyzed using SAS Software (2006 by SAS
Institute Inc., Cary, NC, USA).
Results
Seventy-eight children born as ELBW infants (88% of
available cohort) with a median birthweight of 890 g (25th–
75th percentile: 760–950) and the median gestational age
27 weeks (25th–75th percentile: 26–29) were evaluated at
the mean age 6.7 years. The characteristic of the ELBW
group is presented in Table 1. The control group included
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graphic variables is shown in Table 2. The groups were
similar with respect to age and gender. The ELBW children
were significantly smaller and weighed less than the control
group. None of the neonatal ultrasounds was positive for
congenital renal and urinary tract malformations. None of
the parent’s questionnaire revealed serious urinary tract
infections during infancy.
Mean serum cystatin C levels were significantly higher
(0.64 vs. 0.59 mg/l; p=0.01) in the ELBW group. However,
cystatin C levels in all assessed children were within the
normal range.
Microalbuminuria was detected only in 5/78 ELBW
children and 0/38 control children (p=0.17). Hyperten-
sion was diagnosed in 8/78 ELBW and 2/38 control
children (p=0.5).
The mean renal volume was significantly lower in the
ELBW group (absolute left kidney volume 40 +/−10 ml
vs. 57 +/− 15 ml; p<0.001, absolute right kidney volume
41 +/− 11 ml vs. 56 +/− 15 ml; p<0.001, relative left
kidney volume: 85% +/− 19 vs. 95% +/− 18 p=0.01, relative
right kidney volume: 86% +/− 17 vs. 99% +/− 16 p<0.001).
Abnormally small kidneys (<2/3 of predicted size) were
detected in 19 ELBW and four of the control children
(p=0.08). Renal complications as defined per protocol were
diagnosed only in six ELBW children (Table 3). The
comparison of secondary outcomes between the studied
groups is presented in Table 4. Correlation between kidney
volume and serum cystatin C levels is described in Fig. 1.
Univariate analysis showed that being born as an SGA
infant (p=0.04), poor weight gain during NICU hospitali-
zation (p<0.001), intracranial bleeding (p=0.03) and male
sex (p=0.01) were risk factors for renal complications in
the ELBW group. However, a multivariate logistic regres-
sion revealed that the only independent risk factor was poor
weight gain during NICU hospitalization (Table 5).
Birth weight, median (25th–75th percentile) 890 g (760–950)
Gestational age, median (25th–75th percentile) 27 weeks (26–29)
5-min Apgar score, median; (25th–75th percentile) 6 (5–7)
Prenatal steroids 31 (47)
Mechanical ventilation 77 (91)
Surfactant administration 57 (73)
PDA ligation 21 (27)
Intraventricular hemorrhage grade III–IV 8 (10.2)
Oxygen at 36 weeks postmenstrual age 30 (38)
Postnatal steroids 36 (46)
Confirmed sepsis 16 (20.5)
Weight gain during NICU stay (g/week), mean (SD) 146 (102)
Length of hospitalization, median (25th–75th percentile) 77 (55–103)
Table 1 Baseline characteristics
of extremely low birth weight
(ELBW) participants
a
aExpressed as a number
(percentage) of patients unless
otherwise indicated; PDA patent
ductus arteriosus; NICU neonatal
intensive care unit
Table 2 Comparison of selected demographic and clinical variables between ELBW newborns and the control group
a
ELBW group (n=78) Control group (n=38) p value
Birth weight, median (25th–75th percentile) 890 (760–950) 3,545 (3,409–3,820) <0.001
b
Gestational age, median (25th–75th percentile) 27 (26–29) 40 (39–41) <0.001
b
Female 51 (65) 19 (50) 0.15
c
Vaginal delivery 16 (20) 34 (89) <0.001
c
Multiple pregnancy 10 (13) 0 (0) <0.001
c
Small for gestational age 22 (28) 2 (5) 0.003
c
5 min Apgar score, median; (25th–75th percentile) 6 (4–7) 10 (9–10) <0.001
b
Age at evaluation (years), median (25th–75th percentile) 6.7 (6.4–6.9) 6.9 (6.3–7.3) 0.1
b
Height (cm), mean (SD) 115 (7.9) 125 (7.2) <0.001
d
Height z-score, mean (SD) –1.06 (1.4) 0.28 (0.9) <0.001
d
Weight (kg), mean (SD) 19.6 (4.7) 25.1 (5.3) <0.001
d
Weight z-score, mean (SD) –0.97 (1.05) 0.09 (1.15) <0.001
d
aExpressed as a number (percentage) of patients unless otherwise indicated; p value for Mann–Whitney U test
b, Fisher’s exact test
c, and Student’s t test
d;
ELBW extremely low birth weight
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The article describes the distribution of renal volume and
blood pressure in 6–7-year-olds born with ELBW in
comparison to the control group—children of the same
age but born at term and with normal birth weight.
Microalbuminuria and cystatin C levels were also assessed.
The main outcome variable was renal complications
defined as presence of at least two of the following
abnormalities: abnormal serum cystatin C level, micro-
albuminuria, hypertension, low renal volume. The renal
complications were diagnosed only in six ELBW children.
The difference was not statistically significant. However,
statistically significant differences within secondary out-
comes as mean serum cystatin C levels, night-time mean
blood pressure, night-time blood pressure dipping and
mean systolic and diastolic BP load were detected. Renal
ultrasound assessments revealed significantly smaller renal
volume in 6/7-year-old individuals born with ELBW,
compared to age-matched controls.
The lack of statistically significant differences in the
incidence of renal complications may be connected to the
size of the study group. The study was designed to include
80 ELBW children and 40 children born at term.
Eventually, renal complications were assessed in 78 and
38 children, respectively. The estimated power of the study
is only 67% (to detect 8% difference of prevalence of
primary outcome with alpfa –0.05). However, the study
possesses significant value because: (1) the study group
included all newborns from the whole Malopolska region
born between September, 1, 2002 and August 31, 2004,
who reached the age of 6–7 years. The data concerning the
children involved in our multi-center study comes from all
tertiary referral centers from the Malopolska region. So it is
a complete group of patients, possibly the largest, with a
high percentage of observation (up to 88%). (2) The renal
ELBW group (n=78) Control group (n=38) p value OR (95% CI)
Renal complication 6 (7.7) 0 (0) 0.09
Microalbuminuria 5 (6.4) 0 (0) 0.17
Hypertension 8 (10.3) 2 (5.2) 0.5 2.06 (0.46–0.89)
Low kidney volume 19 (24.3) 4 (10.5) 0.08 2.73 (0.9–8.3)
Table 3 Primary outcome
variables in the studied groups
a
aExpressed as a number (percent-
age) of patients: p value for Fish-
er’s exact test; OR (95% CI), odds
ratio and 95% confidence interval;
ELBW extremely low birth weight
ELBW group (n=78) Control group (n=38) p value
Serum cystatin C level (mg/l) 0.64 (0.07) 0.59 (0.07) 0.01
1
Albuminuria (mg/g creatinine) 5.53 (3.9) 4.9 (3.3) 0.5
1
24-h mean MAP (mmHg) 79 (5.9) 77 (4.4) 0.2
1
Day-time mean MAP (mmHg) 82 (5.8) 80 (4.8) 0.4
1
Night-time mean MAP (mmHg) 75 (5.7) 73 (4.3) 0.26
1
24-h mean MAP (z-score) 0.5 (1.1) –0.3 (0.78) 0.1
1
Day-time mean MAP (z-score) –0.36 (0.9) –0.7 (0.73) 0.5
1
Night-time mean MAP (z-score) 1.15 (0.84) 0.2 (0.72) 0.02
1
Night-time dipping (%) 12 (6.5) 15 (4.5) 0.1
1
Night-time dipping<10% 13 (16.7%) 2 (5.2%) 0.13
2
Systolic BP load (%) 28 (22) 16 (14) <0.01
1
Systolic BP load 0.11
3
<30% 54 31
30–50% 12 6
>50% 12 1
Diastolic BP load (%) 27 (20) 17 (10) <0.01
1
Diastolic BP load
<30% 55 34 0.04
3
30–50% 14 4
>50% 9 0
Absolute kidney volume (ml) 81 (20) 113 (29) <0.001
1
Relative kidney volume (%) 85 (17) 97 (17) <0.001
1
Table 4 Secondary outcome
variables in the studied groups
a
aExpressed as a mean and SD
p value for Student’s t test
b,
Fisher’s exact test
c, Chi-square
test
d
MAP mean arterial pressure dur-
ing 24-h ambulatory blood pres-
sure measurement; BP blood
pressure; ELBW extremely low
birth weight
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was assessed using modern tools to receive very detailed
information. Most previously published studies examined
children with very low birth weight (VLBW), the current
study limited the study group to children with ELBW.
Renal ultrasound standardization was crucial for the value
of the study. Children in the control group were taller and
heavier, and because of the wide disparity between the two
groups the volume of the kidneys was not defined as an
absolute value, but as the standardized value for height and
weight. Inthe absence ofspecifics inliterature, and the lackof
a standardized cut-off point for kidney volume parameter,
below which we can recognize the volume as being too low, a
limit of 2/3 of the standard value was determined and any
outcome, which was below this point was treated as an
indicatoroflowkidneyvolume.Fourpatientsfromthecontrol
group had a decreased rate of renal volume. Three of them
were diagnosed as overweight, therefore we may assume that
the obtained results of low relative kidney volume in these
children are connected with their obesity and, in fact, their
kidney volume is correct.
The major limitations of the study may be: the assumed
criteria of hypertension, the lack of GFR calculation, and
the lack of serum creatinine evaluation.
The ABPM method is still not the reference method for
the diagnosis of hypertension, while in patients with
borderline arterial blood pressure it is much more objective
than a standard blood pressure measurement. This is why
this method was chosen in this study.
There are also studies in which ABPM results seem to be
at least as good as, or even better than, standard blood
pressure measurements. Currently, the gold standard of
diagnosis of hypertension is office sphygmomanometry.
However, we used ABPM in our study because it enables
blood pressure observation to be performed throughout the
day and night in a non-medical environment, and it helps to
quantify the circadian BP variability [15–17]. There are
also publications suggesting a superior correlation of
ABPM with end-organ damage in children and in adults
[18–21]. Due to the character of our study, and because
subjects differed in age and height, we took into account
not the direct results of ABPM, but we converted the data
into z-scores (SDS scores) as described by Wühl et al. [10].
It was expected that the patients in the study group, who
were shorter and thinner, would have a slightly lower blood
pressure than the control group. Yet, they had slightly
higher blood pressure. Moreover, they do not have
nocturnal dipping, which may be the first step in the
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Fig. 1 Correlation between
relative kidney volume
and serum cystatin C levels in
the studied groups
Factor OR (95% CI) p value
Gestational age (per week) 1.84 (0.5–7.4) 0.38
Small for gestational age (per - 1 SD) 1.0 (0.13–9.8) 0.9
Intracranial hemorrhage grade III and IV 12.4 (0.1–999) 0.32
Gain weight during NICU stay (per 10 g/week) 0.67 (0.39–0.94) 0.03
Table 5 Logistic regression
with renal complication as the
outcome variable
NICU neonatal intensive care
unit
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that nocturnal dipping is characteristic for primary hyper-
tension, while in secondary hypertension we do not see the
decline [22]. In our study, we observed no drop in pressure
during the night, which according to Flynn et al. [23]
suggests an increased risk of secondary hypertension in the
study group. In the Bayrakci et al. study [24], which
analyzes the ABPM in preterm patients born small for
gestational age (SGA) at the age 5–17 years, nocturnal
dipping was less than that of controls.
We did not measure serum creatinine levels in all
subjects, so we cannot calculate GFR using standard
formulas. Several studies in adult patients have shown that
cystatin C correlates more or at least as strongly as
creatinine with GFR [25, 26]. Bökenkamp et al. have
reported similar results in children [27]. According to
Harmoinen et al., serum cystatin C appears to represent a
useful and simple tool both for the identification of children
with a reduced GFR (high sensitivity) and for the exclusion
of children with a normal GFR (high specificity) [28].
Moreover, cystatin C concentrations may reflect GFR in
children born with ELBW more closely than serum
creatinine levels, as these children are unaffected by muscle
mass and body weight [29], and at follow-up visits the
ELBW children were significantly smaller and weighed less
than the control group. However, due to the existing
controversies associated with the conversion of the cystatin
C level into GFR, such analysis was not performed.
It deserves attention that the study focused on a high-risk
population for kidney complications development. The
specific character of the studied population (e.g., low
antenatal steroids use) might have influenced the results
obtained and may also lead to difficulties in generalizing
the results.
Very few reports assessing the influence of prematurity on
the size and functioning of kidneys are available. Most of
these reports either concentrate on more mature children or
describe much smaller study groups treated in single medical
centers that were assessed on short- or medium-term basis
(up to 2–5 years).
The results of the longest observations were presented
by Keijzer-Veen et al. [30]. The authors evaluated 20-year-
olds born as very preterm children. They showed that the
absolute and relative kidney length and volume were
significantly lower in the preterm children than in the
control group, but there was no statistical difference in
GFRs among groups of children born very preterm and full-
term. Keizer-Veen et al. observed also that preterm children
have a significantly higher systolic blood pressure [31]. The
major limitation of this study was a small sample size
(n=53). Moreover, the Keizer-Veen et al. study involved
more mature children (mean gestational age was 30 weeks)
than ours [31].
Drougia et al. [7] published results of a prospective
longitudinal study aimed to estimate the renal growth
during the first 2 years of life in the group of 466 children
born above 28 weeks of gestation. The authors found that
the relative kidney volume in the group of not extremely
preterm babies (28–36 weeks) is significantly impaired up
to the second year of life.
Rodriguez-Soriano et al. [2] evaluated 43 ELBW
children aged between 6.1 and 12.4 years. Systolic,
diastolic, and mean blood pressures did not differ from
those of the controls. Mean percentiles for renal length and
volume appeared normal. In comparison to the controls,
plasma creatinine concentration was higher in preterm
children. Only five study subjects (12.5%) fulfilled criteria
for microalbuminuria. The reasons for differences in results
can be associated with the following: the study included
only children born in one center, with the follow-up rate
53%, ultrasound evaluations were done only in preterm
children, not in the control group, and the authors compared
casual BP measurements uncorrected for height of the
patients.
Our observations correspond well with the results from
the Singh and Hoy [32] and Hughson et al. [33] studies,
who assumed that because nephron number, renal size and
albuminuria are strongly interrelated in individuals at risk
of renal diseases, very preterm infants may be at risk of
developing microalbuminuria and renal disease in adult life.
Our results may suggest impaired fetal kidney devel-
opment after preterm birth. Nephrogenesis starts in early
pregnancy, peaks at the 32nd week of gestation,
continues until 36 weeks of gestation, and is correlated
to renal size [32]. The patients from our study group were
born at 27 weeks of gestation; therefore, at birth nephro-
genesis was incomplete. According to Lampl et al. [34]
and Spencer et al. [35] humans born with low birth weight
have a reduced number of nephrons, and fetal weight is
inversely related to kidney volume measured by ultra-
sound. As there is limited postnatal nephrogenesis in
preterm individuals [5, 36], a nephron deficit after preterm
birth may be present throughout life.
A histomorphometric study performed by Rodriguez et
al. in extremely premature and full-term infants revealed
that nephron number highly correlated with gestational age
and that nephrogenesis had stopped 40 days postnatally [5].
Nephron deficit predisposes to reduced renal function in the
adult [32, 33], so babies born preterm, with restricted
postnatal growth, are also at risk [37].
One of the most interesting observations made in the
course of this study is the fact that weight gain in early
infancy is an independent factor of renal complications. As
it has been mentioned, the development of the kidney in
prematurely born infants is unfinished, and a suitable intake
of calories and proteins is necessary for its proper
Pediatr Nephrol (2011) 26:1095–1103 1101completion. The results of experimental animal studies (on
rats) indicate that undernutrition during gestation and early
life can cause permanent reduction in the number of
nephrons [38]. Inadequate nutrition (whether enteral or
parenteral) may impair nephron maturation as well as it
may modify renal function in adulthood [39]. In the future
periods of life, the passage from an unfavorable environ-
ment to a “too favorable” environment can predispose to
pathologies in adulthood (metabolic syndrome) [40]. The
results of a recent study concentrating on children born at
term reveal a close connection between malnutrition and
renal size in late infancy [41].
In conclusion, our data demonstrate that both serum
cystatin C and kidney volume are significantly impaired in
school-age in ELBW children. All children who have
experienced the end point defined by the protocol as a renal
complication, belonged to the study group. In addition, in
these children all other three endpoints (microalbuminuria,
hypertension, low kidney volume) were observed, which
illustrates the broad convergence between the ELBW and
renal complications.
Long-term alterations in renal function and blood
pressure could be determined only with following these
patients up into late adulthood. If these initial findings are
confirmed, the initiation of renoprotective therapy should
be taken into consideration in formerly preterm children.
Acknowledgements This study was supported by an unrestricted
grant from the Polish Ministry of Science (grant number
NN407170734). The authors thank Dr. Karolina Poplawska for
reviewing of the manuscript.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Hack M (2006) Young adult outcomes of very-low-birth-weight
children. Semin Fetal Neonatal Med 11:127–137
2. Rodríguez-Soriano J, Aguirre M, Oliveros R, Vallo A (2005)
Long-term renal follow-up of extremely low birth weight infants.
Pediatr Nephrol 20:579–584
3. Payne N, Finkelstein M, Liu M, Kaempf J, Sharek P, Olsen S
(2010) NICU practices and outcomes associated with 9 years of
quality improvement collaboratives. Pediatrics 125:437–446
4. Kwinta P, Pietrzyk J (2010) Preterm birth and respiratory disease
in later life. Expert Rev Respir Med 4:593–604
5. Rodríguez MM, Gómez AH, Abitbol CL, Chandar JJ, Duara S,
Zilleruelo GE (2004) Histomorphometric analysis of postnatal
glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol
7:17–25
6. Schmidt IM, Chellakooty M, Boisen KA, Damgaard IN, Mau Kai
C, Olgaard K, Main KM (2005) Impaired kidney growth in low-
birth-weight children: distinct effects of maturity and weight for
gestational age. Kidney Int 68:731–740
7. Drougia A, Giapros V, Hotoura E, Papadopoulou F, Argyropoulou
M, Andronikou S (2009) The effects of gestational age and
growth restriction on compensatory kidney growth. Nephrol Dial
Transplant 24:142–148
8. Drukker A, Guignard JP (2002) Renal aspects of the term and
preterm infant: a selective update. Curr Opin Pediatr 14:175–182
9. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN,
Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommen-
dations for blood pressure measurement in humans and experi-
mental animals: Part 1: Blood pressure measurement in humans: a
statement for professionals from the Subcommittee of Professional
and Public Education of the American Heart Association Council
on High Blood Pressure Research. Circulation 111:697–716
10. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German
Working Group on Pediatric Hypertension (2002) Distribution of
24-h ambulatory blood pressure in children: normalized reference
values and role of body dimensions. J Hypertens 20:1995–2007
11. NationalHighBloodPressureEducationProgramWorkingGroupon
High Blood Pressure in Children and Adolescents (2004) The fourth
report on the diagnosis, evaluation, and treatment of high blood
pressure in children and adolescents. Pediatrics 114:555–576
12. Dinkel E, Ertel M, Dittrich M, Peters H, Berres M, Schulte-
Wissermann H (1985) Kidney size in childhood. Sonographical
growth charts for kidney length and volume. Pediatr Radiol
15:38–43
13. Oswald J, Schwentner C, Lunacek A, Deibl M, Bartsch G,
Radmayr C (2004) Age and lean body weight related growth
curves of kidneys using real-time 3-dimensional ultrasound in
pediatric urology. J Urol 172:1991–1994
14. Dupont WD, Plummer WD (1990) Power and sample size
calculations. A review and computer program. Control Clin Trials
11:116–128
15. Loirat C, Azancot-Benisty A, Bossu C, Durand I (1991) Value of
ambulatory blood pressure monitoring in borderline hypertension
in the child. Ann Pediatr (Paris) 38:381–386
16. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti
A (1987) Alerting reaction and rise in blood pressure during
measurement by physician and nurse. Hypertension 9:209–215
17. Sorof JM, Portman RJ (2000) White coat hypertension in children
with elevated casual blood pressure. J Pediatr 137:493–497
18. Perloff D, Sokolow M, Cowan R (1983) The prognostic value of
ambulatory blood pressures. JAMA 249:2792–2798
19. White WB, Schulman P, McCabe EJ, Dey HM (1989) Average
daily blood pressure, not office blood pressure, determines cardiac
function in patients with hypertension. JAMA 261:873–877
20. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de
Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto
J, Webster J (1999) Predicting cardiovascular risk using conven-
tional vs. ambulatory blood pressure in older patients with systolic
hypertension. Systolic Hypertension in Europe Trial Investigators.
JAMA 282:539–546
21. Cuspidi C, Macca G, Salerno M, Michev L, Fusi V, Severgnini B,
Corti C, Meani S, Magrini F, Zanchetti A (2001) Evaluation of
target organ damage in arterial hypertension: which role for
qualitative funduscopic examination? Ital Heart J 2:702–706
22. Díaz LN, Garin EH (2007) Comparison of ambulatory blood
pressure and Task Force criteria to identify pediatric hypertension.
Pediatr Nephrol 22:554–558
23. Flynn JT (2002) Differentiation between primary and secondary
hypertension in children using ambulatory blood pressure moni-
toring. Pediatrics 110:89–93
24. Bayrakci US, Schaefer F, Duzova A, Yigit S, Bakkaloglu A
(2007) Abnormal circadian blood pressure regulation in children
born preterm. J Pediatr 151:399–403
25. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb
AO, Price CP (1995) Serum cystatin C measured by automated
1102 Pediatr Nephrol (2011) 26:1095–1103immunoassay: a more sensitive marker of changes in GFR than
serum creatinine. Kidney Int 47:312–318
26. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-
Ehle P, Lindström V, Grubb A (1994) Serum cystatin C,
determined by a rapid, automated particle-enhanced turbidimetric
method, is a better marker than serum creatinine for glomerular
filtration rate. Clin Chem 40:1921–1926
27. Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D,
Brodehl J (1998) Cystatin C–a new marker of glomerular filtration rate
in children independent of age and height. Pediatrics 101:875–881
28. Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M,
Kouri T (2000) Reference intervals for cystatin C in pre- and full-
term infants and children. Pediatr Nephrol 15:105–108
29. Newman DJ (2002) Cystatin C. Ann Clin Biochem 39:89–104
30. Keijzer-Veen M, Kleinveld H, Lequin M, Dekker F, Nauta J, de
Rijke Y, van der Heijden B (2007) Renal function and size at
young adult age after intrauterine growth restriction and very
premature birth. Am J Kidney Dis 50:542–551
31. Keijzer-Veen M, Dülger A, Dekker F, Nauta J, van der Heijden B
(2010) Very preterm birth is a risk factor for increased systolic
blood pressure at a young adult age. Pediatr Nephrol 25:509–516
32. Singh GR, Hoy WE (2004) Kidney volume, blood pressure, and
albuminuria: findings in an Australian aboriginal community. Am
J Kidney Dis 43:254–259
33. Hughson M, Farris AB, Douglas-Denton R, Hoy WE, Bertram JF
(2003) Glomerular number and size in autopsy kidneys: the
relationship to birth weight. Kidney Int 63:2113–2122
34. Lampl M, Kuzawa CW, Jeanty P (2002) Infants thinner at birth
exhibit smaller kidneys for their size in late gestation in a sample
of fetuses with appropriate growth. Am J Hum Biol 14:398–406
35. Spencer J, Wang Z, Hoy W (2001) Low birth weight and reduced
renal volume in Aboriginal children. Am J Kidney Dis 37:915–920
36. Rodriguez MM, Gomez A, Abitbol C, Chandar J, Montané B,
Zilleruelo G (2005) Comparative renal histomorphometry: a case
study of oligonephropathy of prematurity. Pediatr Nephrol
20:945–949
37. Bacchetta J, Harambat J, Dubourg L, Guy B, Liutkus A,
Canterino I, Kassaï B, Putet G, Cochat P (2009) Both extrauterine
and intrauterine growth restriction impair renal function in
children born very preterm. Kidney Int 76:445–452
38. Harrison M, Langley-Evans SC (2008) Intergenerational program-
ming of impaired nephrogenesis and hypertension in rats
following maternal protein restriction during pregnancy. Br J Nutr
9:1–11
39. Moritz KM, Singh RR, Probyn ME, Denton KM (2009)
Developmental programming of a reduced nephron endowment:
more than just a baby's birth weight. Am J Physiol Renal Physiol
296:F1–F9
40. Fanos V, Puddu M, Reali A, Atzei A, Zaffanello M (2010) Perinatal
nutrient restriction reduces nephron endowment increasing renal
morbidity in adulthood: a review. Early Hum Dev 86:S37–S42
41. Ece A, Gözü A, Bükte Y, Tutanç M, Kocamaz H (2007) The
effect of malnutrition on kidney size in children. Pediatr Nephrol
22:857–863
Pediatr Nephrol (2011) 26:1095–1103 1103